Monte Rosa Therapeutics
GLUE
Insider trades and stock quote 2024-2026
All insider trades at Monte Rosa Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/16/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$23.2 |
$220,219 |
|
7/15/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$23.4 |
$101,730 |
|
7/6/2026
|
Sell |
Townson, Sharon |
Chief Scientific Officer |
$23.7 |
$139,849 |
|
6/30/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$24.5 |
$132,472 |
|
6/29/2026
|
Sell |
Manning, Anthony M. |
Director |
$23.1 |
$231,100 |
|
6/29/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$23.0 |
$137,700 |
|
6/24/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$21.4 |
$642,681 |
|
6/23/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$20.0 |
$43,500 |
|
6/23/2026
|
Sell |
Townson, Sharon |
Chief Scientific Officer |
$20.0 |
$60,000 |
|
6/23/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$20.2 |
$239,522 |
|
6/17/2026
|
Sell |
Townson, Sharon |
Chief Scientific Officer |
$19.0 |
$57,000 |
|
6/17/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$19.0 |
$41,344 |
|
6/1/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$19.6 |
$106,253 |
|
5/29/2026
|
Sell |
Townson, Sharon |
Chief Scientific Officer |
$19.9 |
$119,220 |
|
5/27/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$20.0 |
$43,500 |
|
5/22/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$19.0 |
$41,344 |
|
5/21/2026
|
Sell |
Manning, Anthony M. |
Director |
$18.0 |
$180,100 |
|
5/1/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$18.9 |
$103,447 |
|
4/14/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$17.6 |
$141,125 |
|
4/9/2026
|
Sell |
Nickson, Philip |
Chief Business & Legal Officer |
$17.7 |
$103,413 |
|
3/4/2026
|
Sell |
Dunn, Edmund |
Principal Accounting Officer |
$18.0 |
$2,496 |
|
3/2/2026
|
Sell |
Dunn, Edmund |
Principal Accounting Officer |
$17.5 |
$9,380 |
|
3/2/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$17.9 |
$97,974 |
|
2/27/2026
|
Sell |
Dunn, Edmund |
Principal Accounting Officer |
$18.1 |
$455,506 |
|
2/23/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$19.5 |
$179,161 |
|
1/7/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$23.9 |
$128,372 |
|
1/5/2026
|
Sell |
Townson, Sharon |
Chief Scientific Officer |
$15.2 |
$47,861 |
|
1/5/2026
|
Sell |
Janku, Filip |
Chief Medical Officer |
$15.2 |
$47,861 |
|
1/5/2026
|
Sell |
Warmuth, Markus |
President & CEO |
$15.2 |
$153,748 |
|
1/5/2026
|
Sell |
Dunn, Edmund |
Principal Accounting Officer |
$15.2 |
$15,762 |
|
1/5/2026
|
Sell |
Champoux, Jennifer |
Chief Operating Officer |
$15.2 |
$39,882 |
|
1/5/2026
|
Sell |
Nickson, Philip |
Chief Business & Legal Officer |
$15.2 |
$47,861 |
|
6/3/2025
|
Sell |
Dunn, Edmund |
Principal Accounting Officer |
$4.4 |
$9,174 |
|
3/24/2025
|
Buy |
Leo, Chandra P. |
Director |
$5.8 |
$58,383 |
|
10/29/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$9.2 |
$621,801 |
|
10/28/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$9.7 |
$869,240 |
|
9/20/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$6.5 |
$7,395,203 |
|
9/13/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$6.2 |
$57,100 |
|
9/12/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$6.0 |
$96,309 |
|
9/11/2024
|
Sell |
Versant Venture Capital Vi, L.p. |
Ten Percent Owner |
$6.0 |
$3,251,382 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address